Chao Wu
State Key Laboratory Of Complex Severe And Rare Diseases, Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial.
Journal: Dermatology and therapy
Published: April 10, 2026
Laboratory Parameters Can Serve as Objective Auxiliary Tools for Assessing Disease Severity in Hidradenitis Suppurativa: A 5-Year Period Single-Center Retrospective Study.
Journal: Clinical, cosmetic and investigational dermatology
Published: February 23, 2026
Decreased HDL-C in hidradenitis suppurativa: association with systemic inflammatory phenotype and implications for risk stratification.
Journal: Lipids in health and disease
Published: February 10, 2026
Phenotype-dependent effects of IL-17A inhibitors on lipid profiles in moderate-to-severe plaque psoriasis: a retrospective cohort study.
Journal: Lipids in health and disease
Published: January 28, 2026
Update on Erythrodermic Psoriasis: Proposal of a Management Algorithm by an Innovative Severity Evaluation Approach.
Journal: Psoriasis (Auckland, N.Z.)
Published: April 02, 2025
Spatiotemporal transcriptomics deciphered neutrophil-activated interleukin-36 as driver and effective therapeutic target in Sweet syndrome.
Journal: The British journal of dermatology
Published: March 27, 2025
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS).
Journal: American journal of clinical dermatology
Published: March 23, 2025
Platelet-related parameters as systemic markers of erythrodermic psoriasis.
Journal: European journal of dermatology : EJD
Published: March 20, 2025
Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline.
Journal: The Journal of dermatological treatment
Published: January 19, 2025
Flexible generation of OAM mode reconfigurable beams and spinning OAM beams based on active induced magnetism Huygens' metasurface.
Journal: Optics express
Published: November 22, 2024
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome.
Journal: JAMA dermatology
Published: November 13, 2024
Impact of IL-17A Inhibitors on Serum Uric Acid Levels in Psoriatic Patients with Hyperuricemia: A Prospective Observational Study.
Journal: Psoriasis (Auckland, N.Z.)
Published: July 08, 2024
Last Updated: 09/26/2026